192 related articles for article (PubMed ID: 11233043)
1. Extracorporeal photopheresis for the treatment of lung allograft rejection.
Villanueva J; Bhorade SM; Robinson JA; Husain AN; Garrity ER
Ann Transplant; 2000; 5(3):44-7. PubMed ID: 11233043
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Hachem R; Corris P
Transplantation; 2018 Jul; 102(7):1059-1065. PubMed ID: 29557913
[TBL] [Abstract][Full Text] [Related]
3. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
Jaksch P; Scheed A; Keplinger M; Ernst MB; Dani T; Just U; Nahavandi H; Klepetko W; Knobler R
J Heart Lung Transplant; 2012 Sep; 31(9):950-7. PubMed ID: 22884382
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Pecoraro Y; Carillo C; Diso D; Mantovani S; Cimino G; De Giacomo T; Troiani P; Shafii M; Gherzi L; Amore D; Rendina EA; Venuta F; Anile M
Transplant Proc; 2017 May; 49(4):695-698. PubMed ID: 28457374
[TBL] [Abstract][Full Text] [Related]
5. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
Benden C; Haughton M; Leonard S; Huber LC
J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
[TBL] [Abstract][Full Text] [Related]
7. Bronchiolitis obliterans syndrome development in lung transplantation patients.
Parada MT; Alba A; SepĂșlveda C
Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience.
Benden C; Speich R; Hofbauer GF; Irani S; Eich-Wanger C; Russi EW; Weder W; Boehler A
Transplantation; 2008 Dec; 86(11):1625-7. PubMed ID: 19077900
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
[TBL] [Abstract][Full Text] [Related]
10. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation.
Ensor CR; Rihtarchik LC; Morrell MR; Hayanga JW; Lichvar AB; Pilewski JM; Wisniewski S; Johnson BA; D'Cunha J; Zeevi A; McDyer JF
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28008661
[TBL] [Abstract][Full Text] [Related]
11. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis.
Salerno CT; Park SJ; Kreykes NS; Kulick DM; Savik K; Hertz MI; Bolman RM
J Thorac Cardiovasc Surg; 1999 Jun; 117(6):1063-9. PubMed ID: 10343253
[TBL] [Abstract][Full Text] [Related]
13. Lung transplant recipients on long-term extracorporeal photopheresis.
Isenring B; Robinson C; Buergi U; Schuurmans MM; Kohler M; Huber LC; Benden C
Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28653398
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes.
Raviv Y; D'Ovidio F; Pierre A; Chaparro C; Freeman M; Keshavjee S; Singer LG
Clin Transplant; 2012; 26(1):133-42. PubMed ID: 22313020
[TBL] [Abstract][Full Text] [Related]
15. Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation.
O'Hagan AR; Stillwell PC; Arroliga A; Koo A
Chest; 1999 May; 115(5):1459-62. PubMed ID: 10334173
[TBL] [Abstract][Full Text] [Related]
16. Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation.
Reams BD; Musselwhite LW; Zaas DW; Steele MP; Garantziotis S; Eu PC; Snyder LD; Curl J; Lin SS; Davis RD; Palmer SM
Am J Transplant; 2007 Dec; 7(12):2802-8. PubMed ID: 17924993
[TBL] [Abstract][Full Text] [Related]
17. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
[TBL] [Abstract][Full Text] [Related]
18. Are we near to an effective drug treatment for bronchiolitis obliterans?
Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE
Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection.
Federica M; Nadia S; Monica M; Alessandro C; Tiberio O; Francesco B; Mario V; Maria FA
Clin Transplant; 2011; 25(4):E381-9. PubMed ID: 21418327
[TBL] [Abstract][Full Text] [Related]
20. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]